Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 274

1.

100th Anniversary of Jules Bordet's Nobel Prize: Tribute to a Founding Father of Immunology.

Cavaillon JM, Sansonetti P, Goldman M.

Front Immunol. 2019 Sep 11;10:2114. doi: 10.3389/fimmu.2019.02114. eCollection 2019.

2.

Duclaux, Chamberland, Roux, Grancher, and Metchnikoff: the five musketeers of Louis Pasteur.

Cavaillon JM, Legout S.

Microbes Infect. 2019 Jun 28. pii: S1286-4579(19)30066-8. doi: 10.1016/j.micinf.2019.06.006. [Epub ahead of print]

PMID:
31255675
3.

From septicemia to sepsis 3.0 - from Ignaz Semmelweis to Louis Pasteur.

Cavaillon JM, Chrétien F.

Microbes Infect. 2019 Jun 27. pii: S1286-4579(19)30065-6. doi: 10.1016/j.micinf.2019.06.005. [Epub ahead of print]

PMID:
31255674
4.

Duclaux, Chamberland, Roux, Grancher, and Metchnikoff: the five musketeers of Louis Pasteur.

Cavaillon JM, Legout S.

Genes Immun. 2019 May;20(5):344-356. doi: 10.1038/s41435-019-0064-1. Epub 2019 Mar 29.

PMID:
30923360
5.

From septicemia to sepsis 3.0-from Ignaz Semmelweis to Louis Pasteur.

Cavaillon JM, Chrétien F.

Genes Immun. 2019 May;20(5):371-382. doi: 10.1038/s41435-019-0063-2. Epub 2019 Mar 22. Review.

PMID:
30903106
6.

Inner sensors of endotoxin - implications for sepsis research and therapy.

Skirecki T, Cavaillon JM.

FEMS Microbiol Rev. 2019 May 1;43(3):239-256. doi: 10.1093/femsre/fuz004. Review.

PMID:
30844058
7.

Biomarker cruises in sepsis: who is the CAPTAIN? Discussion on "Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study".

Briassoulis G, Briassoulis P, Miliaraki M, Ilia S, Parlato M, Philippart F, Rouquette A, Moucadel V, Cavaillon JM, Misset B; Combined Approach for The eArly diagnosis of INfection in sepsis (CAPTAIN) study group.

Intensive Care Med. 2019 Jan;45(1):132-133. doi: 10.1007/s00134-018-5451-y. Epub 2019 Jan 7. No abstract available.

PMID:
30617463
8.

Immunosuppression is Inappropriately Qualifying the Immune Status of Septic and SIRS Patients.

Cavaillon JM, Giamarellos-Bourboulis EJ.

Shock. 2019 Sep;52(3):307-317. doi: 10.1097/SHK.0000000000001266.

PMID:
30239420
9.

Correction to: Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis.

Osuchowski MF, Ayala A, Bahrami S, Bauer M, Boros M, Cavaillon JM, Chaudry IH, Coopersmith CM, Deutschman C, Drechsler S, Efron P, Frostell C, Fritsch G, Gozdzik W, Hellman J, Huber-Lang M, Inoue S, Knapp S, Kozlov AV, Libert C, Marshall JC, Moldawer LL, Radermacher P, Redl H, Remick DG, Singer M, Thiemermann C, Wang P, Wiersinga WJ, Xiao X, Zingarelli B.

Infection. 2018 Oct;46(5):745-747. doi: 10.1007/s15010-018-1197-2.

10.

Minimum quality threshold in pre-clinical sepsis studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis.

Osuchowski MF, Ayala A, Bahrami S, Bauer M, Boros M, Cavaillon JM, Chaudry IH, Coopersmith CM, Deutschman C, Drechsler S, Efron P, Frostell C, Fritsch G, Gozdzik W, Hellman J, Huber-Lang M, Inoue S, Knapp S, Kozlov AV, Libert C, Marshall JC, Moldawer LL, Radermacher P, Redl H, Remick DG, Singer M, Thiemermann C, Wang P, Wiersinga WJ, Xiao X, Zingarelli B.

Intensive Care Med Exp. 2018 Aug 14;6(1):26. doi: 10.1186/s40635-018-0189-y. Review.

11.

Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): An International Expert Consensus Initiative for Improvement of Animal Modeling in Sepsis.

Osuchowski MF, Ayala A, Bahrami S, Bauer M, Boros M, Cavaillon JM, Chaudry IH, Coopersmith CM, Deutschman CS, Drechsler S, Efron P, Frostell C, Fritsch G, Gozdzik W, Hellman J, Huber-Lang M, Inoue S, Knapp S, Kozlov AV, Libert C, Marshall JC, Moldawer LL, Radermacher P, Redl H, Remick DG, Singer M, Thiemermann C, Wang P, Wiersinga WJ, Xiao X, Zingarelli B.

Shock. 2018 Oct;50(4):377-380. doi: 10.1097/SHK.0000000000001212.

12.

Part II: Minimum Quality Threshold in Preclinical Sepsis Studies (MQTiPSS) for Types of Infections and Organ Dysfunction Endpoints.

Libert C, Ayala A, Bauer M, Cavaillon JM, Deutschman C, Frostell C, Knapp S, Kozlov AV, Wang P, Osuchowski MF, Remick DG.

Shock. 2019 Jan;51(1):23-32. doi: 10.1097/SHK.0000000000001242.

PMID:
30106873
13.

Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis.

Osuchowski MF, Ayala A, Bahrami S, Bauer M, Boros M, Cavaillon JM, Chaudry IH, Coopersmith CM, Deutschman C, Drechsler S, Efron P, Frostell C, Fritsch G, Gozdzik W, Hellman J, Huber-Lang M, Inoue S, Knapp S, Kozlov AV, Libert C, Marshall JC, Moldawer LL, Radermacher P, Redl H, Remick DG, Singer M, Thiemermann C, Wang P, Wiersinga WJ, Xiao X, Zingarelli B.

Infection. 2018 Oct;46(5):687-691. doi: 10.1007/s15010-018-1183-8. Review. Erratum in: Infection. 2018 Sep 17;:.

14.

Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study.

Parlato M, Philippart F, Rouquette A, Moucadel V, Puchois V, Blein S, Bedos JP, Diehl JL, Hamzaoui O, Annane D, Journois D, Ben Boutieb M, Estève L, Fitting C, Treluyer JM, Pachot A, Adib-Conquy M, Cavaillon JM, Misset B; Captain Study Group.

Intensive Care Med. 2018 Jul;44(7):1061-1070. doi: 10.1007/s00134-018-5228-3. Epub 2018 Jun 30.

PMID:
29959455
15.

Gastro-protective, therapeutic and anti-inflammatory activities of Pistacia lentiscus L. fatty oil against ethanol-induced gastric ulcers in rats.

Boutemine IM, Amri M, Amir ZC, Fitting C, Mecherara-Idjeri S, Layaida K, Sennoun N, Berkane S, Cavaillon JM, Touil-Boukoffa C.

J Ethnopharmacol. 2018 Oct 5;224:273-282. doi: 10.1016/j.jep.2018.05.040. Epub 2018 May 31.

PMID:
29859303
16.

Specific features of human monocytes activation by monophosphoryl lipid A.

Chentouh R, Fitting C, Cavaillon JM.

Sci Rep. 2018 May 4;8(1):7096. doi: 10.1038/s41598-018-25367-y.

17.

Historical links between toxinology and immunology.

Cavaillon JM.

Pathog Dis. 2018 Apr 1;76(3). doi: 10.1093/femspd/fty019. Review.

PMID:
29718183
18.

A Novel Polyaminocarboxylate Compound To Treat Murine Pulmonary Aspergillosis by Interfering with Zinc Metabolism.

Laskaris P, Vicentefranqueira R, Helynck O, Jouvion G, Calera JA, du Merle L, Suzenet F, Buron F, de Sousa RA, Mansuy D, Cavaillon JM, Latgé JP, Munier-Lehmann H, Ibrahim-Granet O.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e02510-17. doi: 10.1128/AAC.02510-17. Print 2018 Jun.

19.

Compartment diversity in innate immune reprogramming.

Rasid O, Cavaillon JM.

Microbes Infect. 2018 Mar;20(3):156-165. doi: 10.1016/j.micinf.2017.12.008. Epub 2017 Dec 27. Review.

PMID:
29287986
20.

Exotoxins and endotoxins: Inducers of inflammatory cytokines.

Cavaillon JM.

Toxicon. 2018 Jul;149:45-53. doi: 10.1016/j.toxicon.2017.10.016. Epub 2017 Oct 19. Review.

PMID:
29056305
21.

Treatment of Cyclosporin A retains host defense against invasive pulmonary aspergillosis in a non-immunosuppressive murine model by preserving the myeloid cell population.

Wong SSW, Rasid O, Laskaris P, Fekkar A, Cavaillon JM, Steinbach WJ, Ibrahim-Granet O.

Virulence. 2017 Nov 17;8(8):1744-1752. doi: 10.1080/21505594.2017.1339007. Epub 2017 Jul 6.

22.

Cytokine and iNOS profiles in lymph nodes of dogs naturally infected with Leishmania infantum and their association with the parasitic DNA load and clinical and histopathological features.

de Vasconcelos TC, Doyen N, Cavaillon JM, Bruno SF, de Campos MP, de Miranda LH, Madeira Mde F, Belo VS, Figueiredo FB.

Vet Parasitol. 2016 Aug 30;227:8-14. doi: 10.1016/j.vetpar.2016.07.017. Epub 2016 Jul 16.

23.

Local Microenvironment Controls the Compartmentalization of NK Cell Responses during Systemic Inflammation in Mice.

Rasid O, Ciulean IS, Fitting C, Doyen N, Cavaillon JM.

J Immunol. 2016 Sep 15;197(6):2444-54. doi: 10.4049/jimmunol.1601040. Epub 2016 Aug 12.

24.

Administration of Zinc Chelators Improves Survival of Mice Infected with Aspergillus fumigatus both in Monotherapy and in Combination with Caspofungin.

Laskaris P, Atrouni A, Calera JA, d'Enfert C, Munier-Lehmann H, Cavaillon JM, Latgé JP, Ibrahim-Granet O.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5631-9. doi: 10.1128/AAC.00324-16. Print 2016 Oct.

25.

Centenary of the death of Elie Metchnikoff: a visionary and an outstanding team leader.

Cavaillon JM, Legout S.

Microbes Infect. 2016 Oct;18(10):577-594. doi: 10.1016/j.micinf.2016.05.008. Epub 2016 Jun 7. Review.

PMID:
27288152
26.

Reducing hypoxia and inflammation during invasive pulmonary aspergillosis by targeting the Interleukin-1 receptor.

Gresnigt MS, Rekiki A, Rasid O, Savers A, Jouvion G, Dannaoui E, Parlato M, Fitting C, Brock M, Cavaillon JM, van de Veerdonk FL, Ibrahim-Granet O.

Sci Rep. 2016 May 24;6:26490. doi: 10.1038/srep26490.

27.

A Transcriptomic Biomarker to Quantify Systemic Inflammation in Sepsis - A Prospective Multicenter Phase II Diagnostic Study.

Bauer M, Giamarellos-Bourboulis EJ, Kortgen A, Möller E, Felsmann K, Cavaillon JM, Guntinas-Lichius O, Rutschmann O, Ruryk A, Kohl M, Wlotzka B, Rußwurm S, Marshall JC, Reinhart K.

EBioMedicine. 2016 Apr;6:114-125. doi: 10.1016/j.ebiom.2016.03.006. Epub 2016 Mar 8.

28.

Cathepsin B-Deficient Mice Resolve Leishmania major Inflammation Faster in a T Cell-Dependent Manner.

Rasid O, Mériaux V, Khan EM, Borde C, Ciulean IS, Fitting C, Manoury B, Cavaillon JM, Doyen N.

PLoS Negl Trop Dis. 2016 May 16;10(5):e0004716. doi: 10.1371/journal.pntd.0004716. eCollection 2016 May.

29.

Infection-Mediated Priming of Phagocytes Protects against Lethal Secondary Aspergillus fumigatus Challenge.

Savers A, Rasid O, Parlato M, Brock M, Jouvion G, Ryffel B, Cavaillon JM, Eberl G, Ibrahim-Granet O.

PLoS One. 2016 Apr 14;11(4):e0153829. doi: 10.1371/journal.pone.0153829. eCollection 2016.

30.

Recent developments in severe sepsis research: from bench to bedside and back.

Rasid O, Cavaillon JM.

Future Microbiol. 2016;11(2):293-314. doi: 10.2217/fmb.15.133. Epub 2016 Feb 5. Review.

PMID:
26849633
31.

Comparative Study of Injury Models for Studying Muscle Regeneration in Mice.

Hardy D, Besnard A, Latil M, Jouvion G, Briand D, Thépenier C, Pascal Q, Guguin A, Gayraud-Morel B, Cavaillon JM, Tajbakhsh S, Rocheteau P, Chrétien F.

PLoS One. 2016 Jan 25;11(1):e0147198. doi: 10.1371/journal.pone.0147198. eCollection 2016.

32.

Intravenous Immunoglobulin with Enhanced Polyspecificity Improves Survival in Experimental Sepsis and Aseptic Systemic Inflammatory Response Syndromes.

Djoumerska-Alexieva I, Roumenina L, Pashov A, Dimitrov J, Hadzhieva M, Lindig S, Voynova E, Dimitrova P, Ivanovska N, Bockmeyer C, Stefanova Z, Fitting C, Bläss M, Claus R, von Gunten S, Kaveri S, Cavaillon JM, Bauer M, Vassilev T.

Mol Med. 2016 Apr;21(1):1002-1010. doi: 10.2119/molmed.2014.00224. Epub 2016 Mar 31.

33.

The fiendish behavior of TNF can be counteracted by microRNA.

Cavaillon JM.

EMBO Mol Med. 2015 Aug;7(8):989-91. doi: 10.15252/emmm.201505380.

34.

TLR9 activation is triggered by the excess of stimulatory versus inhibitory motifs present in Trypanosomatidae DNA.

Khan ME, Borde C, Rocha EP, Mériaux V, Maréchal V, Escoll P, Goyard S, Cavaillon JM, Manoury B, Doyen N.

PLoS Negl Trop Dis. 2014 Nov 13;8(11):e3308. doi: 10.1371/journal.pntd.0003308. eCollection 2014 Nov.

35.

RGS16 restricts the pro-inflammatory response of monocytes.

Suurväli J, Pahtma M, Saar R, Paalme V, Nutt A, Tiivel T, Saaremäe M, Fitting C, Cavaillon JM, Rüütel Boudinot S.

Scand J Immunol. 2015 Jan;81(1):23-30. doi: 10.1111/sji.12250.

36.

Host response biomarkers in the diagnosis of sepsis: a general overview.

Parlato M, Cavaillon JM.

Methods Mol Biol. 2015;1237:149-211. doi: 10.1007/978-1-4939-1776-1_15. Review.

PMID:
25319788
37.

Bacterial translocation and plasma cytokines during transcatheter and open-heart aortic valve implantation.

Adrie C, Parlato M, Salmi L, Adib-Conquy M, Bical O, Deleuze P, Fitting C, Cavaillon JM, Monchi M.

Shock. 2015 Jan;43(1):62-7. doi: 10.1097/SHK.0000000000000262.

PMID:
25202829
38.

Altered immune status of circulating T lymphocytes during sepsis: children also.

Cavaillon JM.

Crit Care. 2014 Aug 14;18(4):486. doi: 10.1186/s13054-014-0486-0.

39.

Joseph Alouf (1929-2014).

Cavaillon JM.

FEMS Microbiol Lett. 2014 Jun;355(1):90-1. doi: 10.1111/1574-6968.12455. No abstract available.

40.

Is boosting the immune system in sepsis appropriate?

Cavaillon JM, Eisen D, Annane D.

Crit Care. 2014 Mar 24;18(2):216. doi: 10.1186/cc13787. Review.

41.

Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.

Guihot A, Luyt CE, Parrot A, Rousset D, Cavaillon JM, Boutolleau D, Fitting C, Pajanirassa P, Mallet A, Fartoukh M, Agut H, Musset L, Zoorob R, Kirilovksy A, Combadière B, van der Werf S, Autran B, Carcelain G; FluBAL Study Group.

Am J Respir Crit Care Med. 2014 May 15;189(10):1240-9. doi: 10.1164/rccm.201311-2071OC.

PMID:
24646009
42.

CD24-triggered caspase-dependent apoptosis via mitochondrial membrane depolarization and reactive oxygen species production of human neutrophils is impaired in sepsis.

Parlato M, Souza-Fonseca-Guimaraes F, Philippart F, Misset B; Captain Study Group, Adib-Conquy M, Cavaillon JM.

J Immunol. 2014 Mar 1;192(5):2449-59. doi: 10.4049/jimmunol.1301055. Epub 2014 Feb 5.

43.

Protective or deleterious role of scavenger receptors SR-A and CD36 on host resistance to Staphylococcus aureus depends on the site of infection.

Blanchet C, Jouvion G, Fitting C, Cavaillon JM, Adib-Conquy M.

PLoS One. 2014 Jan 31;9(1):e87927. doi: 10.1371/journal.pone.0087927. eCollection 2014.

44.

TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals.

Adib-Conquy M, Scott-Algara D, Cavaillon JM, Souza-Fonseca-Guimaraes F.

Immunol Cell Biol. 2014 Mar;92(3):256-62. doi: 10.1038/icb.2013.99. Epub 2013 Dec 24. Review.

PMID:
24366517
45.

Bench-to-bedside review: Platelets and active immune functions - new clues for immunopathology?

Garraud O, Hamzeh-Cognasse H, Pozzetto B, Cavaillon JM, Cognasse F.

Crit Care. 2013 Aug 27;17(4):236. doi: 10.1186/cc12716. Review.

46.

Bench-to-bedside review: Natural killer cells in sepsis - guilty or not guilty?

Souza-Fonseca-Guimaraes F, Cavaillon JM, Adib-Conquy M.

Crit Care. 2013 Aug 27;17(4):235. doi: 10.1186/cc12700. Review.

47.

Interferon-γ and granulocyte/monocyte colony-stimulating factor production by natural killer cells involves different signaling pathways and the adaptor stimulator of interferon genes (STING).

Souza-Fonseca-Guimaraes F, Parlato M, de Oliveira RB, Golenbock D, Fitzgerald K, Shalova IN, Biswas SK, Cavaillon JM, Adib-Conquy M.

J Biol Chem. 2013 Apr 12;288(15):10715-21. doi: 10.1074/jbc.M112.435602. Epub 2013 Feb 26.

48.

Toll-like receptors expression and interferon-γ production by NK cells in human sepsis.

Souza-Fonseca-Guimaraes F, Parlato M, Philippart F, Misset B, Cavaillon JM, Adib-Conquy M; Captain study group.

Crit Care. 2012 Oct 25;16(5):R206. doi: 10.1186/cc11838.

49.

Sir Marc Armand Ruffer and Giulio Bizzozero: the first reports on efferocytosis.

Cavaillon JM.

J Leukoc Biol. 2013 Jan;93(1):39-43. doi: 10.1189/jlb.0712361. Epub 2012 Sep 14.

PMID:
22984135
50.

Lung microenvironment contributes to the resistance of alveolar macrophages to develop tolerance to endotoxin*.

Philippart F, Fitting C, Cavaillon JM.

Crit Care Med. 2012 Nov;40(11):2987-96. doi: 10.1097/CCM.0b013e31825b8d57.

PMID:
22878679

Supplemental Content

Loading ...
Support Center